Optimizing patient access with evidence of product value, effectiveness, and safety from early development through loss of exclusivity.

Learn More
The Evidence Forum

The fall issue of The Evidence Forum is out

Read content related to the relevant issues facing companies along the path to approval and access

Read Now
Career Opportunities

Join Our Growing Team

We’re looking for smart, creative, dedicated, people to join us in optimizing patient access with evidence of value, effectiveness, and safety

Learn More
White Paper

Health Economics in China: Changing Pharmaceutical Pricing and Reimbursement

Discover how health economic modeling tools, RWE, and collaboration with local data providers support value demonstration of innovative patent drugs in China

Read Now
White Paper

Research Operations for Secondary use of Clinical Sites’ EMR

Learn about the benefits and challenges of using electronic medical records for systemic observational studies

Read Now
hands on a laptop
On-Demand Webinars

Browse Our Library of On-Demand Webinars

Discover our experts' insights on trending industry topics

Learn More

Our Work In Action

150+ Drugs/Therapies

supported in the past year

30+ Global Extended Access Programs

in the last 3 years alone with thousands of patients transitioning smoothly from investigational to commercial

130+ Payer Submissions

across 20+ countries in the past 5 years, including reversal of multiple NICE decisions

17 of the 20 Top-Selling Drugs

in 2018 supported in the past 5 years

130+ Peer-Reviewed Publications

and 220+ research posters and presentations per year

Learn More

Latest Publications

Hematology

Using Social Media to Uncover Treatment Experiences and Decisions in Patients With AML or MDS Who Are Ineligible for Intensive Chemotherapy: Patient-Centric Qualitative Data Analysis

  • Journal of Medical Internet Research
  • January 2020
Oncology

Budget Impact Of Including Avelumab As A Second-Line Treatment For Locally Advanced Or Metastatic Urothelial Cancer In The United States: Commercial And Medicare Payer Perspectives

  • ClinicoEconomics and Outcomes Research
  • January 2020
Oncology

Value Assessment of Immuno-Oncology in the Treatment of Rare Tumors in the Era of Accelerated Conditional Approvals

  • Future Oncology
  • January 2020
Read More About Our Publications
What We Do

What We Do

Real-World Evidence

Obtain real-world evidence of value by extracting data from existing sources, collecting primary data, and conducting hybrid studies.

Patient-Centered Research

Develop and evaluate clinical outcomes assessments to support labeling and promotional claims.

Evidence Synthesis, Modeling & Communication

Provide a truly connected value story, supported by strong evidence

Market Access

Optimize market access with cogent payer insights, expert-informed evidence strategy, and persuasive communication of product value.

Interventional Studies

Provide peri- and post-approval evidence via dedicated global operations and custom-tailored study designs.

Pragmatic Studies

Explore patient-centered outcomes and comparative effectiveness using pragmatic studies with adaptive designs.

Medical Writing

Expert medical writing, including medical information, study documentation, and publications, tailored to the peri- and post-approval environment.
Anuraag Kansal, PhD, Sr. Research Leader & Director, Disease & Trial Simulation, Modeling & Simulation at Evidera

In Our Own Words

Our work simulating Alzheimer’s disease progression allows us to offer clients insight into their trial designs, simulate outcomes of alternative designs, and enable clients to anticipate results and make decisions accordingly.

CUP Case Study
Case Study

Robust Modeling Helped Convince NICE to Reverse Their Decision

Learn how Evidera’s experts helped to improve access to a mCRPC treatment in a country with traditionally conservative reimbursement for these therapies.

Read More
Case Study

Compassionate Use Program: Rapid Drug Delivery to Patients in Need

Learn how Evidera, as part of PPD, created a global program across 38 countries to provide treatment within 24-48 hours to 3,100 patients.

Read More
Careers

Meaningful Work at Every Level

We assess candidates across a variety of scientific and operational functions. From leaders in their fields, to those who are new to the industry. We employ people who have a proactive mind-set when it comes to the work they do and helping the people they work with.

Learn More